SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-154362
Filing Date
2024-06-04
Accepted
2024-06-04 17:06:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d828028d424b3.htm 424B3 163133
2 GRAPHIC g828028g03m03.jpg GRAPHIC 51787
  Complete submission text file 0001193125-24-154362.txt   231283
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279452 | Film No.: 241019213
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)